Announced Tue, 14 Jul · 12:24 IST
Reg 74(5) certificate submitted for quarter ended 30 June 2026
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹25.35
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—————+2.6+10.5+12.0—+10.2————
Up moveDown movePending
AI summary
Shelter Pharma submitted the Regulation 74(5) certificate to BSE for the quarter ended 30 June 2026. The certificate, issued by registrar Bigshare Services, confirms that the regulation is not applicable to the company as all shares are held in demat form and no requests for rematerialisation or dematerialisation were received during the quarter. This is a routine compliance filing.
Likely market impact
Routine compliance filing. No material impact on shareholders or stock price. All shares continue to be held in demat form.